Welcome to Neurology Clinical Research!

Neurology is one of the largest Clinical Research enterprises in the University of Colorado School of Medicine

We offer a variety of Clinical Research:

• Drug Studies
• Non-drug Treatments and Interventions
• Device Studies
• Observational (blood draw studies, questionnaire studies)
• Biobanking
• Patient-reported Outcomes
• Imaging (MEG, MRI, fMRI, PET scan)
• Quality Improvements
• Translational Lab and Tissue Bank

Explore our Neurology Research Laboratories:

• Alzheimer's Disease and Cognition
• CU Neuro-Magnetic Laboratories
• Neuroimmunology: Autoimmune Inflammatory Disorders of the Central Nervous System
• Neurovirology: Role of Varicella Zoster Virus in the Central Nervous System
• Neurovirology: Epigenetic Regulation of Varicella Zoster Virus
• Neurovirology: In Vivo Models of Varicella-Zoster Virus Neurotropism
• Neurovirology: Virus Infections of the Central Nervous System
  

Image: Anschutz Health Sciences Building (AHSB), the location of our outpatient Clinical and Translational Research Center (CTRC).

Neurology Clinical Research Study Statuses CY 2025

*69% Non-Industry Funded, 31% Industry Funded

Neurology Clinical Research CY 2020-2024 Growth Comparison

Subspecialty CY 2025 Clinical Study Statistics

*Excludes secondary use/chart review

Grant Summary CY 2025

Highlighted Studies CY 2025

New to Clinical Research?  

Learn more about clinical research by visiting the following resources:  

• What are Research Studies? by the University of Colorado Anschutz Medical Campus Research Studies Team
• The Center for Information and Study on Clinical Research Participation (CISCRP) is first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research and the role each party plays in the process.
  • The CISCRP Community Resources webpage contains a number of contact information-containing resources available to anyone seeking information about clinical research, both general and disease-specific.
• Clinicaltrials.gov Glossary of Common Site Terms
• The National Institutes of Health (NIH) - Clinical Trails and You
• PubMed is a free (as in money) resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally.
• Access for ALL in ALS - Funded by the National Institutes of Health (NIH), the Access for ALL in ALS Consortium (ALL ALS), is a community of two coordination centers and 35 research sites across the United States, conducting a combined longitudinal natural history study and biomarker collection study for ALS. ALL ALS research engages with people currently living with ALS, potential ALS gene carriers, and family members, friends, and community partners to better understand all stages of ALS disease progression.

Common Terms:

• Arm: a group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
• Clinical study: a research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: interventional studies (also called clinical trials) and observational studies.
• Clinical trial: another name for an interventional study.
• ClinicalTrials.gov identifier (NCT number): the unique identification code given to each clinical study upon registration at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).
• Eligibility criteria: the key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.
• Informed consent: a process used by researchers to communicate to potential and enrolled participants the risks and potential benefits of participating in a clinical study.
• Intervention/treatment: a process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
• Observational study: a type of clinical study in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific interventions/treatment.
• Placebo: an inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or intervention/treatment being studied.
• Principal Investigator (PI): the person who is responsible for the scientific and technical direction of the entire clinical study.
• Protocol: the written description of a clinical study. It includes the study's objectives, design, and methods. It may also include relevant scientific background and statistical information.
• Research Services Professional (RSP): the title of clinical research coordinators at the University of Colorado. The RSP coordinates research visits and helps the PI carefully manage the participant’s care.
• Sponsor: the organization or person who initiates the study and who has authority and control over the study.
• U.S. Food and Drug Administration (FDA): an agency within the U.S. Department of Health and Human Services. The FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the Nation's food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.

*all above definitions were copied from the Clinicaltrials.gov Glossary of Common Site Terms

Research is critical in helping to advance our knowledge of neurological diseases in order to best care for our patients. We also welcome Healthy Volunteers to participate in our studies!  Join us and become a part of the Neurology Clinical Research family as we aim to become a Center of Research Excellence!

For questions about our clinical research, please contact the Neurology Research Recruitment Team at 303-724-4644 or [email protected] .

Local Neurology Events

---

Clinical Research by Subspecialty

---

Get Connected

---

If you think you may be eligible for one of these studies or if you would like more information, please fill out our Neurology Research Interest Web Form or contact us at N[email protected] or 303-724-4644.